

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 6.74447457 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.74447457 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.95746026 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 5.57492804 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.57492804 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.29052669 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.29052669 |
| 8 | protein retention in ER lumen (GO:0006621) | 5.18546723 |
| 9 | COPII vesicle coating (GO:0048208) | 4.99094867 |
| 10 | lactate metabolic process (GO:0006089) | 4.86943162 |
| 11 | positive regulation of protein autophosphorylation (GO:0031954) | 4.72496342 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 4.57281066 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.47955013 |
| 14 | cysteine metabolic process (GO:0006534) | 4.46956863 |
| 15 | intestinal cholesterol absorption (GO:0030299) | 4.32689708 |
| 16 | protein carboxylation (GO:0018214) | 4.29726268 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.29726268 |
| 18 | regulation of hexokinase activity (GO:1903299) | 4.20607346 |
| 19 | regulation of glucokinase activity (GO:0033131) | 4.20607346 |
| 20 | valine metabolic process (GO:0006573) | 4.19335134 |
| 21 | exocrine pancreas development (GO:0031017) | 4.16566353 |
| 22 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.12969992 |
| 23 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.07487166 |
| 24 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.06123365 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.04644646 |
| 26 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.02722521 |
| 27 | 4-hydroxyproline metabolic process (GO:0019471) | 3.97738662 |
| 28 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.95508860 |
| 29 | * positive regulation of nuclease activity (GO:0032075) | 3.93080034 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.92039956 |
| 31 | complement activation, alternative pathway (GO:0006957) | 3.91635739 |
| 32 | homocysteine metabolic process (GO:0050667) | 3.87638694 |
| 33 | tryptophan metabolic process (GO:0006568) | 3.85857681 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 3.85217336 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.79866599 |
| 36 | proteasome assembly (GO:0043248) | 3.79387677 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 3.79277838 |
| 38 | positive regulation of glycolytic process (GO:0045821) | 3.78033310 |
| 39 | ketone body metabolic process (GO:1902224) | 3.77943118 |
| 40 | tryptophan catabolic process (GO:0006569) | 3.77934085 |
| 41 | indole-containing compound catabolic process (GO:0042436) | 3.77934085 |
| 42 | indolalkylamine catabolic process (GO:0046218) | 3.77934085 |
| 43 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.74933285 |
| 44 | signal peptide processing (GO:0006465) | 3.74900451 |
| 45 | regulation of protein activation cascade (GO:2000257) | 3.74581087 |
| 46 | glyoxylate metabolic process (GO:0046487) | 3.74484823 |
| 47 | kynurenine metabolic process (GO:0070189) | 3.74444778 |
| 48 | cellular modified amino acid catabolic process (GO:0042219) | 3.74388621 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 3.72617065 |
| 50 | lysine metabolic process (GO:0006553) | 3.71748951 |
| 51 | lysine catabolic process (GO:0006554) | 3.71748951 |
| 52 | urea cycle (GO:0000050) | 3.70253250 |
| 53 | urea metabolic process (GO:0019627) | 3.70253250 |
| 54 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 3.70237851 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.65932778 |
| 56 | reverse cholesterol transport (GO:0043691) | 3.65264910 |
| 57 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.64630035 |
| 58 | keratinocyte development (GO:0003334) | 3.63714130 |
| 59 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.60431711 |
| 60 | * cellular response to unfolded protein (GO:0034620) | 3.59570058 |
| 61 | regulation of complement activation (GO:0030449) | 3.56943960 |
| 62 | * regulation of nuclease activity (GO:0032069) | 3.54491930 |
| 63 | regulation of fibrinolysis (GO:0051917) | 3.53105320 |
| 64 | * ER-nucleus signaling pathway (GO:0006984) | 3.50059492 |
| 65 | negative regulation of acute inflammatory response (GO:0002674) | 3.47666535 |
| 66 | tyrosine metabolic process (GO:0006570) | 3.47355136 |
| 67 | bile acid metabolic process (GO:0008206) | 3.42230065 |
| 68 | zinc ion transport (GO:0006829) | 3.40885792 |
| 69 | nitrogen cycle metabolic process (GO:0071941) | 3.40211306 |
| 70 | regulation of protein autophosphorylation (GO:0031952) | 3.40202973 |
| 71 | respiratory chain complex IV assembly (GO:0008535) | 3.39870155 |
| 72 | aromatic amino acid family metabolic process (GO:0009072) | 3.38620842 |
| 73 | * cellular response to topologically incorrect protein (GO:0035967) | 3.38026360 |
| 74 | transcytosis (GO:0045056) | 3.37461088 |
| 75 | sequestering of metal ion (GO:0051238) | 3.37262268 |
| 76 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.35669619 |
| 77 | drug transmembrane transport (GO:0006855) | 3.34619378 |
| 78 | platelet dense granule organization (GO:0060155) | 3.34487062 |
| 79 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.33029375 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.31789580 |
| 81 | regulation of protein glycosylation (GO:0060049) | 3.29484523 |
| 82 | regulation of meiosis I (GO:0060631) | 3.25712480 |
| 83 | plasma lipoprotein particle remodeling (GO:0034369) | 3.25104958 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 3.25104958 |
| 85 | macromolecular complex remodeling (GO:0034367) | 3.25104958 |
| 86 | serine family amino acid catabolic process (GO:0009071) | 3.23734880 |
| 87 | bile acid and bile salt transport (GO:0015721) | 3.23607680 |
| 88 | endocrine pancreas development (GO:0031018) | 3.23023750 |
| 89 | vesicle coating (GO:0006901) | 3.22739947 |
| 90 | regulation of triglyceride catabolic process (GO:0010896) | 3.21679724 |
| 91 | * response to endoplasmic reticulum stress (GO:0034976) | 3.18031867 |
| 92 | triglyceride homeostasis (GO:0070328) | 3.17083264 |
| 93 | acylglycerol homeostasis (GO:0055090) | 3.17083264 |
| 94 | inositol phosphate catabolic process (GO:0071545) | 3.16864379 |
| 95 | intestinal absorption (GO:0050892) | 3.15794380 |
| 96 | hormone catabolic process (GO:0042447) | 3.15227877 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.14839916 |
| 98 | coenzyme catabolic process (GO:0009109) | 3.12853105 |
| 99 | cellular amino acid catabolic process (GO:0009063) | 3.10643937 |
| 100 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.10482865 |
| 101 | phospholipid efflux (GO:0033700) | 3.10453730 |
| 102 | 2-oxoglutarate metabolic process (GO:0006103) | 3.10128046 |
| 103 | negative regulation of protein autophosphorylation (GO:0031953) | 3.10024194 |
| 104 | negative regulation of cholesterol transport (GO:0032375) | 3.09041462 |
| 105 | negative regulation of sterol transport (GO:0032372) | 3.09041462 |
| 106 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.07886458 |
| 107 | negative regulation of neurological system process (GO:0031645) | 3.05533645 |
| 108 | amino-acid betaine metabolic process (GO:0006577) | 3.03804381 |
| 109 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.01802033 |
| 110 | nucleotide transmembrane transport (GO:1901679) | 3.00648921 |
| 111 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.00186459 |
| 112 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.99520197 |
| 113 | inositol phosphate dephosphorylation (GO:0046855) | 2.99520197 |
| 114 | short-chain fatty acid metabolic process (GO:0046459) | 2.98479615 |
| 115 | peptidyl-asparagine modification (GO:0018196) | 2.98273884 |
| 116 | indolalkylamine metabolic process (GO:0006586) | 2.97140220 |
| 117 | lipoprotein metabolic process (GO:0042157) | 2.94041881 |
| 118 | positive regulation of actin filament depolymerization (GO:0030836) | 2.92434949 |
| 119 | cytochrome complex assembly (GO:0017004) | 2.92310071 |
| 120 | xenobiotic catabolic process (GO:0042178) | 2.91761584 |
| 121 | ER overload response (GO:0006983) | 2.91514120 |
| 122 | plasma lipoprotein particle clearance (GO:0034381) | 2.90576176 |
| 123 | cholesterol efflux (GO:0033344) | 2.90319363 |
| 124 | response to pheromone (GO:0019236) | 2.90219301 |
| 125 | branched-chain amino acid metabolic process (GO:0009081) | 2.90127229 |
| 126 | complement activation, classical pathway (GO:0006958) | 2.90037545 |
| 127 | protein maturation by protein folding (GO:0022417) | 2.89972821 |
| 128 | fatty acid oxidation (GO:0019395) | 2.89089728 |
| 129 | ethanol oxidation (GO:0006069) | 2.86142325 |
| 130 | tricarboxylic acid metabolic process (GO:0072350) | 2.84817817 |
| 131 | fatty acid beta-oxidation (GO:0006635) | 2.84224924 |
| 132 | peptide hormone processing (GO:0016486) | 2.84180189 |
| 133 | lipid oxidation (GO:0034440) | 2.83185091 |
| 134 | polyol catabolic process (GO:0046174) | 2.81917069 |
| 135 | glutamate metabolic process (GO:0006536) | 2.80624458 |
| 136 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.78764615 |
| 137 | regulation of B cell apoptotic process (GO:0002902) | 2.78023195 |
| 138 | cullin deneddylation (GO:0010388) | 2.75489343 |
| 139 | inositol phosphate-mediated signaling (GO:0048016) | 2.75336557 |
| 140 | intestinal epithelial cell development (GO:0060576) | 2.75253613 |
| 141 | positive regulation of meiosis (GO:0045836) | 2.73136440 |
| 142 | regulation of acrosome reaction (GO:0060046) | 2.71393560 |
| 143 | positive regulation of respiratory burst (GO:0060267) | 2.67557902 |
| 144 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.65613775 |
| 145 | negative regulation of complement activation (GO:0045916) | 2.61646469 |
| 146 | branched-chain amino acid catabolic process (GO:0009083) | 2.59668225 |
| 147 | positive regulation of meiotic cell cycle (GO:0051446) | 2.55856743 |
| 148 | protein deneddylation (GO:0000338) | 2.55790215 |
| 149 | sphingosine metabolic process (GO:0006670) | 2.55732843 |
| 150 | nitric oxide mediated signal transduction (GO:0007263) | 2.55037773 |
| 151 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.53396460 |
| 152 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.53396460 |
| 153 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.53396460 |
| 154 | negative regulation of protein activation cascade (GO:2000258) | 2.51991535 |
| 155 | eosinophil chemotaxis (GO:0048245) | 2.51288829 |
| 156 | nucleotide-sugar metabolic process (GO:0009225) | 2.50638346 |
| 157 | prenylation (GO:0097354) | 2.50531647 |
| 158 | protein prenylation (GO:0018342) | 2.50531647 |
| 159 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.50478080 |
| 160 | kidney morphogenesis (GO:0060993) | 2.46605015 |
| 161 | positive regulation of calcium ion import (GO:0090280) | 2.43671195 |
| 162 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.43335311 |
| 163 | parental behavior (GO:0060746) | 2.43133650 |
| 164 | S-adenosylmethionine metabolic process (GO:0046500) | 2.42548911 |
| 165 | endosome to melanosome transport (GO:0035646) | 2.41719846 |
| 166 | endosome to pigment granule transport (GO:0043485) | 2.41719846 |
| 167 | synapsis (GO:0007129) | 2.41303956 |
| 168 | protein K11-linked deubiquitination (GO:0035871) | 2.41167218 |
| 169 | mannosylation (GO:0097502) | 2.41112924 |
| 170 | negative regulation of protein oligomerization (GO:0032460) | 2.40966102 |
| 171 | positive regulation of macroautophagy (GO:0016239) | 2.39471719 |
| 172 | nitric oxide biosynthetic process (GO:0006809) | 2.39409346 |
| 173 | response to hydroperoxide (GO:0033194) | 2.37844795 |
| 174 | insulin secretion (GO:0030073) | 2.37315642 |
| 175 | protein K6-linked ubiquitination (GO:0085020) | 2.36895917 |
| 176 | regulation of Rac protein signal transduction (GO:0035020) | 2.36590438 |
| 177 | C-terminal protein lipidation (GO:0006501) | 2.36117199 |
| 178 | keratan sulfate catabolic process (GO:0042340) | 2.35793821 |
| 179 | DNA deamination (GO:0045006) | 2.35265508 |
| 180 | sphingoid metabolic process (GO:0046519) | 2.35170831 |
| 181 | early endosome to late endosome transport (GO:0045022) | 2.32233963 |
| 182 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.32091722 |
| 183 | prostate gland growth (GO:0060736) | 2.30387607 |
| 184 | negative regulation of JUN kinase activity (GO:0043508) | 2.29994159 |
| 185 | L-fucose catabolic process (GO:0042355) | 2.29929258 |
| 186 | fucose catabolic process (GO:0019317) | 2.29929258 |
| 187 | L-fucose metabolic process (GO:0042354) | 2.29929258 |
| 188 | developmental pigmentation (GO:0048066) | 2.29559348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.44335303 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.12568980 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.39175484 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.11281685 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.53044273 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.20345969 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.69151603 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.53630138 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.46552636 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.41375977 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09472146 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.77709581 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.72400646 |
| 14 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.62443627 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.46681936 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33585854 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.27887613 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.27837356 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.25061768 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.21164106 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.12883178 |
| 22 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.12385763 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.12236730 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09819571 |
| 25 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.01958380 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.98697785 |
| 27 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.98189558 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.97593048 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.96935677 |
| 30 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.94923059 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92991846 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89622940 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.88657510 |
| 34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.88095696 |
| 35 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.87511202 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.84714863 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.77311227 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.70382644 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69129740 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68058110 |
| 41 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.66338761 |
| 42 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.57841254 |
| 43 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56678534 |
| 44 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.56596734 |
| 45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.56386899 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56331376 |
| 47 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.55179497 |
| 48 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54265716 |
| 49 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.53534546 |
| 50 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.53109443 |
| 51 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.53081191 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52589496 |
| 53 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.51372261 |
| 54 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.50463397 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.48094469 |
| 56 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.46810970 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46294414 |
| 58 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46254753 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45630463 |
| 60 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.45535105 |
| 61 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.43011775 |
| 62 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42479051 |
| 63 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.42373239 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41598559 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41087191 |
| 66 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.41024331 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40977633 |
| 68 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38769882 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37184597 |
| 70 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.36748047 |
| 71 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.36338643 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36302066 |
| 73 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.36073929 |
| 74 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.35622688 |
| 75 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.35453751 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35200621 |
| 77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35019579 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.34679104 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.34354863 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.34354863 |
| 81 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.33353017 |
| 82 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33218375 |
| 83 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32861585 |
| 84 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.32548571 |
| 85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32361794 |
| 86 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.31721407 |
| 87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30708045 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28608091 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28369579 |
| 90 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.26830184 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25617143 |
| 92 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25496819 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23841979 |
| 94 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23652211 |
| 95 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.22752437 |
| 96 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22723726 |
| 97 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.22101892 |
| 98 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22101892 |
| 99 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.21871502 |
| 100 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21867552 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20911530 |
| 102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20674162 |
| 103 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.19405135 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.19364836 |
| 105 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.19009438 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18361218 |
| 107 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18308910 |
| 108 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17093865 |
| 109 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.16856339 |
| 110 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.16633233 |
| 111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16525279 |
| 112 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16083876 |
| 113 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15996200 |
| 114 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.14945148 |
| 115 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.14870025 |
| 116 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13801356 |
| 117 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13125975 |
| 118 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12976208 |
| 119 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.12863889 |
| 120 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.12568722 |
| 121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11892865 |
| 122 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.11434348 |
| 123 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.11222614 |
| 124 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11164191 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10930000 |
| 126 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10216045 |
| 127 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09987327 |
| 128 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09987327 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09649157 |
| 130 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.09077691 |
| 131 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08909529 |
| 132 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07585080 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06402582 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.04692437 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02404547 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02404547 |
| 137 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02095373 |
| 138 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01361090 |
| 139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99698558 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99185804 |
| 141 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97573730 |
| 142 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96690767 |
| 143 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94647005 |
| 144 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94105022 |
| 145 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93586447 |
| 146 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92333979 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90588554 |
| 148 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.89578769 |
| 149 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87480716 |
| 150 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86614318 |
| 151 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.86453796 |
| 152 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.86453796 |
| 153 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85302139 |
| 154 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82864187 |
| 155 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82017031 |
| 156 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.81472931 |
| 157 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80785751 |
| 158 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.80684070 |
| 159 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80111976 |
| 160 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78998724 |
| 161 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78631590 |
| 162 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78126072 |
| 163 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.76962098 |
| 164 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76382751 |
| 165 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.76239788 |
| 166 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.74812072 |
| 167 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.74539953 |
| 168 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.72781858 |
| 169 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72601496 |
| 170 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.71270955 |
| 171 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.71085229 |
| 172 | CJUN_26792858_Chip-Seq_BT549_Human | 0.69982733 |
| 173 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68725364 |
| 174 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67928023 |
| 175 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.67118515 |
| 176 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.66145415 |
| 177 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.66032278 |
| 178 | AR_20517297_ChIP-Seq_VCAP_Human | 0.65448975 |
| 179 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.65380072 |
| 180 | ATF3_27146783_Chip-Seq_COLON_Human | 0.65016589 |
| 181 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.63493252 |
| 182 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.62109413 |
| 183 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.61418604 |
| 184 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.60898473 |
| 185 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60816711 |
| 186 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.60483292 |
| 187 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.60070471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.72692202 |
| 2 | MP0005365_abnormal_bile_salt | 5.03550965 |
| 3 | MP0005360_urolithiasis | 4.62725130 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.22700605 |
| 5 | MP0003252_abnormal_bile_duct | 3.41771530 |
| 6 | MP0001666_abnormal_nutrient_absorption | 3.25384019 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.09633257 |
| 8 | MP0003195_calcinosis | 2.93442910 |
| 9 | MP0005083_abnormal_biliary_tract | 2.89489349 |
| 10 | MP0000372_irregular_coat_pigmentation | 2.84252246 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.80962068 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.72748235 |
| 13 | MP0005220_abnormal_exocrine_pancreas | 2.65377667 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.46400320 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.37934721 |
| 16 | MP0002163_abnormal_gland_morphology | 2.33369482 |
| 17 | MP0003868_abnormal_feces_composition | 2.31855630 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.23364743 |
| 19 | MP0005332_abnormal_amino_acid | 2.19788419 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.16647160 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.06530958 |
| 22 | MP0009840_abnormal_foam_cell | 2.06264641 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 2.04411785 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.02644268 |
| 25 | MP0005174_abnormal_tail_pigmentation | 1.98230551 |
| 26 | MP0004043_abnormal_pH_regulation | 1.96775473 |
| 27 | MP0002693_abnormal_pancreas_physiology | 1.89459544 |
| 28 | * MP0009643_abnormal_urine_homeostasis | 1.83722091 |
| 29 | MP0005075_abnormal_melanosome_morpholog | 1.82213537 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.81977916 |
| 31 | MP0000609_abnormal_liver_physiology | 1.81115439 |
| 32 | * MP0001944_abnormal_pancreas_morphology | 1.80182005 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.79965840 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.75667651 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.75552735 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.73842666 |
| 37 | MP0000516_abnormal_urinary_system | 1.72865177 |
| 38 | MP0005367_renal/urinary_system_phenotyp | 1.72865177 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.72614960 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.71777923 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.70899845 |
| 42 | MP0000015_abnormal_ear_pigmentation | 1.66029367 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.65822635 |
| 44 | MP0003787_abnormal_imprinting | 1.59451056 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.54366497 |
| 46 | MP0002938_white_spotting | 1.51911779 |
| 47 | MP0005319_abnormal_enzyme/_coenzyme | 1.44579920 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.44477676 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.42428747 |
| 50 | MP0003011_delayed_dark_adaptation | 1.41617664 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.40242410 |
| 52 | MP0002090_abnormal_vision | 1.39626155 |
| 53 | MP0006054_spinal_hemorrhage | 1.38103851 |
| 54 | MP0001756_abnormal_urination | 1.37641056 |
| 55 | * MP0002078_abnormal_glucose_homeostasis | 1.36728660 |
| 56 | MP0000427_abnormal_hair_cycle | 1.35817087 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.35601750 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.35220837 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.31072529 |
| 60 | MP0001765_abnormal_ion_homeostasis | 1.29671443 |
| 61 | MP0002102_abnormal_ear_morphology | 1.28717846 |
| 62 | MP0005253_abnormal_eye_physiology | 1.28710142 |
| 63 | MP0000371_diluted_coat_color | 1.26848760 |
| 64 | MP0005408_hypopigmentation | 1.25352036 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.24413404 |
| 66 | MP0002928_abnormal_bile_duct | 1.23050834 |
| 67 | MP0009384_cardiac_valve_regurgitation | 1.21218641 |
| 68 | MP0003718_maternal_effect | 1.15260269 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.13023095 |
| 70 | MP0005395_other_phenotype | 1.12992875 |
| 71 | MP0001764_abnormal_homeostasis | 1.12226374 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.10738359 |
| 73 | MP0003283_abnormal_digestive_organ | 1.09838690 |
| 74 | MP0005171_absent_coat_pigmentation | 1.09560024 |
| 75 | MP0005379_endocrine/exocrine_gland_phen | 1.06376350 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 1.06034448 |
| 77 | MP0003186_abnormal_redox_activity | 1.05118110 |
| 78 | MP0005647_abnormal_sex_gland | 1.04598916 |
| 79 | MP0003786_premature_aging | 1.04289766 |
| 80 | MP0002896_abnormal_bone_mineralization | 1.03546520 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 1.03249413 |
| 82 | MP0006082_CNS_inflammation | 1.02756401 |
| 83 | MP0000598_abnormal_liver_morphology | 1.02074708 |
| 84 | MP0001984_abnormal_olfaction | 1.01637801 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00419778 |
| 86 | MP0000613_abnormal_salivary_gland | 0.99057828 |
| 87 | MP0010307_abnormal_tumor_latency | 0.98457680 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 0.96806417 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 0.94540418 |
| 90 | MP0009785_altered_susceptibility_to | 0.93009046 |
| 91 | MP0008057_abnormal_DNA_replication | 0.91504349 |
| 92 | MP0005310_abnormal_salivary_gland | 0.91493129 |
| 93 | MP0002148_abnormal_hypersensitivity_rea | 0.91294046 |
| 94 | MP0001661_extended_life_span | 0.90971918 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.89529237 |
| 96 | MP0005410_abnormal_fertilization | 0.88125165 |
| 97 | MP0010368_abnormal_lymphatic_system | 0.86905505 |
| 98 | MP0003724_increased_susceptibility_to | 0.86862108 |
| 99 | * MP0009642_abnormal_blood_homeostasis | 0.86310423 |
| 100 | MP0002638_abnormal_pupillary_reflex | 0.86122729 |
| 101 | MP0008469_abnormal_protein_level | 0.85660810 |
| 102 | MP0002295_abnormal_pulmonary_circulatio | 0.84277557 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.84005186 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.83279886 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.83180518 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.83123171 |
| 107 | MP0003959_abnormal_lean_body | 0.82300699 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.80464138 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.79664626 |
| 110 | MP0000604_amyloidosis | 0.79528730 |
| 111 | MP0005334_abnormal_fat_pad | 0.78671208 |
| 112 | MP0001324_abnormal_eye_pigmentation | 0.78281870 |
| 113 | MP0002254_reproductive_system_inflammat | 0.78263881 |
| 114 | MP0009764_decreased_sensitivity_to | 0.78088938 |
| 115 | MP0003045_fibrosis | 0.77620862 |
| 116 | MP0005167_abnormal_blood-brain_barrier | 0.76458007 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.76393058 |
| 118 | MP0005670_abnormal_white_adipose | 0.75669856 |
| 119 | MP0004484_altered_response_of | 0.75515452 |
| 120 | MP0000647_abnormal_sebaceous_gland | 0.75315304 |
| 121 | MP0005165_increased_susceptibility_to | 0.75049657 |
| 122 | MP0002168_other_aberrant_phenotype | 0.74900121 |
| 123 | MP0009763_increased_sensitivity_to | 0.73619877 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.73055200 |
| 125 | MP0008872_abnormal_physiological_respon | 0.72961300 |
| 126 | MP0000383_abnormal_hair_follicle | 0.72141143 |
| 127 | * MP0003953_abnormal_hormone_level | 0.71890525 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.71433420 |
| 129 | MP0005275_abnormal_skin_tensile | 0.69754219 |
| 130 | MP0002060_abnormal_skin_morphology | 0.69749829 |
| 131 | MP0005535_abnormal_body_temperature | 0.67919517 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.67429295 |
| 133 | MP0000639_abnormal_adrenal_gland | 0.65791412 |
| 134 | MP0002006_tumorigenesis | 0.65647616 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.65614363 |
| 136 | MP0005448_abnormal_energy_balance | 0.64429132 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.64351743 |
| 138 | MP0005375_adipose_tissue_phenotype | 0.64000783 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.63496975 |
| 140 | MP0002971_abnormal_brown_adipose | 0.61738484 |
| 141 | MP0005666_abnormal_adipose_tissue | 0.61290339 |
| 142 | MP0004130_abnormal_muscle_cell | 0.60169824 |
| 143 | MP0004947_skin_inflammation | 0.58959761 |
| 144 | MP0001533_abnormal_skeleton_physiology | 0.58953002 |
| 145 | MP0004185_abnormal_adipocyte_glucose | 0.58450949 |
| 146 | MP0004272_abnormal_basement_membrane | 0.58127069 |
| 147 | MP0000462_abnormal_digestive_system | 0.56895566 |
| 148 | MP0003795_abnormal_bone_structure | 0.56179121 |
| 149 | MP0003436_decreased_susceptibility_to | 0.55816635 |
| 150 | MP0003638_abnormal_response/metabolism_ | 0.55640707 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.45086933 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.39062162 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.16708569 |
| 4 | Abnormality of the intrinsic pathway (HP:0010989) | 4.87239676 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.81381708 |
| 6 | Abnormality of the common coagulation pathway (HP:0010990) | 4.66992940 |
| 7 | Hypoglycemic seizures (HP:0002173) | 4.61448570 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.57230167 |
| 9 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.44409567 |
| 10 | Xanthomatosis (HP:0000991) | 4.36282991 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 4.24743376 |
| 12 | Ketoacidosis (HP:0001993) | 4.13580724 |
| 13 | Ketosis (HP:0001946) | 4.08514472 |
| 14 | Fat malabsorption (HP:0002630) | 3.81131443 |
| 15 | Complement deficiency (HP:0004431) | 3.81051331 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69757419 |
| 17 | Symptomatic seizures (HP:0011145) | 3.66793275 |
| 18 | Hypothermia (HP:0002045) | 3.61105760 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 3.57008577 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.34040927 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.34040927 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.29618314 |
| 23 | Hyperglycemia (HP:0003074) | 3.25058853 |
| 24 | Generalized aminoaciduria (HP:0002909) | 3.24055809 |
| 25 | Large for gestational age (HP:0001520) | 3.17942112 |
| 26 | Tongue fasciculations (HP:0001308) | 3.12563965 |
| 27 | Late onset (HP:0003584) | 3.06403392 |
| 28 | Dysostosis multiplex (HP:0000943) | 3.06195702 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.04227201 |
| 30 | Joint hemorrhage (HP:0005261) | 3.02921807 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.00224081 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.00224081 |
| 33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.00224081 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.97411671 |
| 35 | Hematochezia (HP:0002573) | 2.96624521 |
| 36 | Hyperglycinuria (HP:0003108) | 2.95619949 |
| 37 | Hypolipoproteinemia (HP:0010981) | 2.94520714 |
| 38 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.92643992 |
| 39 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.92643992 |
| 40 | Gout (HP:0001997) | 2.90191692 |
| 41 | Steatorrhea (HP:0002570) | 2.89683285 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.85106886 |
| 43 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.82908723 |
| 44 | Hypoplasia of the fovea (HP:0007750) | 2.82908723 |
| 45 | Hyperammonemia (HP:0001987) | 2.80713376 |
| 46 | Hyperglycinemia (HP:0002154) | 2.80275807 |
| 47 | Abnormality of complement system (HP:0005339) | 2.78726691 |
| 48 | Hypoalphalipoproteinemia (HP:0003233) | 2.78243298 |
| 49 | Albinism (HP:0001022) | 2.77302179 |
| 50 | Metaphyseal dysplasia (HP:0100255) | 2.76482358 |
| 51 | Abnormality of vitamin B metabolism (HP:0004340) | 2.75853160 |
| 52 | Enlarged penis (HP:0000040) | 2.73755435 |
| 53 | Abnormality of glycine metabolism (HP:0010895) | 2.71539922 |
| 54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71539922 |
| 55 | Epidermoid cyst (HP:0200040) | 2.70516036 |
| 56 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.68973119 |
| 57 | Methylmalonic acidemia (HP:0002912) | 2.68285903 |
| 58 | Muscle fibrillation (HP:0010546) | 2.67837927 |
| 59 | Patchy hypopigmentation of hair (HP:0011365) | 2.66181941 |
| 60 | Myocardial infarction (HP:0001658) | 2.63138673 |
| 61 | Vacuolated lymphocytes (HP:0001922) | 2.60520550 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.57419547 |
| 63 | Intestinal atresia (HP:0011100) | 2.57253101 |
| 64 | Hypokinesia (HP:0002375) | 2.56357988 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.55029623 |
| 66 | Conjunctival hamartoma (HP:0100780) | 2.49554643 |
| 67 | Skin nodule (HP:0200036) | 2.48037730 |
| 68 | Progressive macrocephaly (HP:0004481) | 2.47821834 |
| 69 | Pancreatitis (HP:0001733) | 2.46777705 |
| 70 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.46151057 |
| 71 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.44255547 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.43581160 |
| 73 | Abnormality of the fovea (HP:0000493) | 2.40053158 |
| 74 | Protuberant abdomen (HP:0001538) | 2.38666941 |
| 75 | Thyroiditis (HP:0100646) | 2.37751420 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.36224318 |
| 77 | Hyperbilirubinemia (HP:0002904) | 2.35561555 |
| 78 | Hamartoma of the eye (HP:0010568) | 2.34239247 |
| 79 | Congenital sensorineural hearing impairment (HP:0008527) | 2.32455351 |
| 80 | Neoplasm of the adrenal cortex (HP:0100641) | 2.31476674 |
| 81 | Abnormality of methionine metabolism (HP:0010901) | 2.31278628 |
| 82 | Disproportionate short-trunk short stature (HP:0003521) | 2.30649382 |
| 83 | Hepatocellular carcinoma (HP:0001402) | 2.29057743 |
| 84 | Abnormality of the renal cortex (HP:0011035) | 2.28041850 |
| 85 | Cutaneous melanoma (HP:0012056) | 2.25924148 |
| 86 | Increased CSF protein (HP:0002922) | 2.25825049 |
| 87 | Menorrhagia (HP:0000132) | 2.23376278 |
| 88 | Abdominal distention (HP:0003270) | 2.21912819 |
| 89 | Methylmalonic aciduria (HP:0012120) | 2.21826235 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.20849276 |
| 91 | Hepatic necrosis (HP:0002605) | 2.20608529 |
| 92 | Abnormality of vitamin metabolism (HP:0100508) | 2.16927129 |
| 93 | Back pain (HP:0003418) | 2.13295798 |
| 94 | Insulin resistance (HP:0000855) | 2.11696328 |
| 95 | Retinal atrophy (HP:0001105) | 2.09693452 |
| 96 | White forelock (HP:0002211) | 2.09433557 |
| 97 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.09064506 |
| 98 | Abnormal protein glycosylation (HP:0012346) | 2.09064506 |
| 99 | Abnormal glycosylation (HP:0012345) | 2.09064506 |
| 100 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.09064506 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.08274374 |
| 102 | Hydroxyprolinuria (HP:0003080) | 2.08274374 |
| 103 | Mitral stenosis (HP:0001718) | 2.07716908 |
| 104 | Esophageal varix (HP:0002040) | 2.06825237 |
| 105 | Follicular hyperkeratosis (HP:0007502) | 2.06439930 |
| 106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.06174686 |
| 107 | Neoplasm of the adrenal gland (HP:0100631) | 2.03887770 |
| 108 | Systemic lupus erythematosus (HP:0002725) | 2.03488207 |
| 109 | Type I transferrin isoform profile (HP:0003642) | 2.02895081 |
| 110 | Prostate neoplasm (HP:0100787) | 2.02864350 |
| 111 | Elevated alkaline phosphatase (HP:0003155) | 2.02035250 |
| 112 | Breast carcinoma (HP:0003002) | 2.01820850 |
| 113 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.00975298 |
| 114 | Pancreatic cysts (HP:0001737) | 2.00478938 |
| 115 | Stomatitis (HP:0010280) | 2.00415770 |
| 116 | Increased CSF lactate (HP:0002490) | 2.00387024 |
| 117 | Renal cortical cysts (HP:0000803) | 2.00139372 |
| 118 | Sensorimotor neuropathy (HP:0007141) | 1.99891836 |
| 119 | Hypomagnesemia (HP:0002917) | 1.99010023 |
| 120 | Vascular calcification (HP:0004934) | 1.97032280 |
| 121 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.96666158 |
| 122 | Exocrine pancreatic insufficiency (HP:0001738) | 1.96375481 |
| 123 | Hypercholesterolemia (HP:0003124) | 1.95956451 |
| 124 | Congenital, generalized hypertrichosis (HP:0004540) | 1.95556097 |
| 125 | Gaze-evoked nystagmus (HP:0000640) | 1.95200898 |
| 126 | Thoracolumbar scoliosis (HP:0002944) | 1.94901681 |
| 127 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.94358663 |
| 128 | Acute necrotizing encephalopathy (HP:0006965) | 1.93488229 |
| 129 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92604753 |
| 130 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92604753 |
| 131 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92604753 |
| 132 | Cardiovascular calcification (HP:0011915) | 1.92239421 |
| 133 | Abnormal tarsal ossification (HP:0008369) | 1.91969717 |
| 134 | Hyperactive renin-angiotensin system (HP:0000841) | 1.91453809 |
| 135 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.91338565 |
| 136 | Glomerulonephritis (HP:0000099) | 1.89908028 |
| 137 | Abnormal foot bone ossification (HP:0010675) | 1.89811982 |
| 138 | Metabolic acidosis (HP:0001942) | 1.89295349 |
| 139 | Acute encephalopathy (HP:0006846) | 1.84650361 |
| 140 | Alkalosis (HP:0001948) | 1.84624676 |
| 141 | Proximal tubulopathy (HP:0000114) | 1.83684339 |
| 142 | Abnormal cartilage morphology (HP:0002763) | 1.82914963 |
| 143 | Sensory axonal neuropathy (HP:0003390) | 1.82753403 |
| 144 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81515322 |
| 145 | Dicarboxylic aciduria (HP:0003215) | 1.81515322 |
| 146 | Irritability (HP:0000737) | 1.79872495 |
| 147 | Spastic diplegia (HP:0001264) | 1.78254954 |
| 148 | Abnormal pancreas size (HP:0012094) | 1.78212620 |
| 149 | Fair hair (HP:0002286) | 1.77727688 |
| 150 | Acute hepatic failure (HP:0006554) | 1.77360373 |
| 151 | Abnormal albumin level (HP:0012116) | 1.77281461 |
| 152 | Hypoalbuminemia (HP:0003073) | 1.77281461 |
| 153 | Delayed CNS myelination (HP:0002188) | 1.74896483 |
| 154 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74157782 |
| 155 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.73675928 |
| 156 | Mitochondrial inheritance (HP:0001427) | 1.73539691 |
| 157 | Generalized hypopigmentation of hair (HP:0011358) | 1.73469836 |
| 158 | Abnormality of urine glucose concentration (HP:0011016) | 1.73138548 |
| 159 | Glycosuria (HP:0003076) | 1.73138548 |
| 160 | Hepatocellular necrosis (HP:0001404) | 1.72629116 |
| 161 | Abnormal biliary tract morphology (HP:0012440) | 1.70764990 |
| 162 | Beaking of vertebral bodies (HP:0004568) | 1.70262697 |
| 163 | Death in childhood (HP:0003819) | 1.69247378 |
| 164 | Congenital stationary night blindness (HP:0007642) | 1.66883002 |
| 165 | Generalized hypopigmentation (HP:0007513) | 1.66752711 |
| 166 | Adrenal hypoplasia (HP:0000835) | 1.66715691 |
| 167 | Hemiparesis (HP:0001269) | 1.66021592 |
| 168 | Diminished movement (HP:0002374) | 1.65325853 |
| 169 | Tubular atrophy (HP:0000092) | 1.65113185 |
| 170 | Delayed gross motor development (HP:0002194) | 1.64987398 |
| 171 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.63754132 |
| 172 | Aqueductal stenosis (HP:0002410) | 1.62648891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.60841546 |
| 2 | TAOK3 | 4.64682749 |
| 3 | INSRR | 4.19702164 |
| 4 | BCKDK | 3.94883391 |
| 5 | FRK | 3.86365065 |
| 6 | SIK1 | 2.88388354 |
| 7 | ACVR1B | 2.75619060 |
| 8 | TRIB3 | 2.58439814 |
| 9 | BMPR1B | 2.54289598 |
| 10 | TRIM28 | 2.53964147 |
| 11 | FGFR4 | 2.31956890 |
| 12 | LATS1 | 2.31034155 |
| 13 | MAPK15 | 2.29934010 |
| 14 | ERBB3 | 2.17503842 |
| 15 | SCYL2 | 2.08508884 |
| 16 | FLT3 | 2.06708973 |
| 17 | PLK2 | 2.02530751 |
| 18 | PASK | 1.97336269 |
| 19 | EIF2AK1 | 1.94962361 |
| 20 | PTK6 | 1.92142747 |
| 21 | PKN2 | 1.89184733 |
| 22 | OXSR1 | 1.86881589 |
| 23 | WNK3 | 1.84300886 |
| 24 | MKNK2 | 1.83044900 |
| 25 | MAP3K12 | 1.78081089 |
| 26 | MAP3K2 | 1.77355416 |
| 27 | GRK1 | 1.76680962 |
| 28 | MAP4K2 | 1.60599603 |
| 29 | STK24 | 1.60007773 |
| 30 | STK38L | 1.57199326 |
| 31 | PIK3CG | 1.55663152 |
| 32 | PLK3 | 1.51063066 |
| 33 | IRAK3 | 1.45362218 |
| 34 | PDGFRA | 1.40287914 |
| 35 | JAK1 | 1.39836156 |
| 36 | TRPM7 | 1.37988869 |
| 37 | ADRBK2 | 1.34413263 |
| 38 | EPHA3 | 1.33914421 |
| 39 | HIPK2 | 1.33508963 |
| 40 | TNIK | 1.31642332 |
| 41 | TYK2 | 1.23115898 |
| 42 | WNK4 | 1.22845036 |
| 43 | MST1R | 1.21551763 |
| 44 | NEK9 | 1.15846346 |
| 45 | MAP3K3 | 1.15438938 |
| 46 | EIF2AK3 | 1.14917522 |
| 47 | BMPR2 | 1.14524471 |
| 48 | JAK2 | 1.13049976 |
| 49 | PDK2 | 1.10523562 |
| 50 | MET | 1.10212815 |
| 51 | JAK3 | 1.08848512 |
| 52 | AKT3 | 1.07412005 |
| 53 | EPHB1 | 1.06806130 |
| 54 | FGFR3 | 1.05506922 |
| 55 | TGFBR2 | 1.00541300 |
| 56 | PTK2 | 0.98222840 |
| 57 | ZAK | 0.96698081 |
| 58 | RIPK1 | 0.94722771 |
| 59 | PRKCE | 0.94653912 |
| 60 | MKNK1 | 0.91701484 |
| 61 | LRRK2 | 0.89899971 |
| 62 | MAP2K2 | 0.88967757 |
| 63 | NUAK1 | 0.86432939 |
| 64 | BCR | 0.86078884 |
| 65 | ZAP70 | 0.84985392 |
| 66 | PHKG1 | 0.84954908 |
| 67 | PHKG2 | 0.84954908 |
| 68 | CSNK1G1 | 0.84499920 |
| 69 | FER | 0.82631336 |
| 70 | SIK3 | 0.82536550 |
| 71 | ITK | 0.82328930 |
| 72 | MYLK | 0.81645855 |
| 73 | MAP3K1 | 0.81296726 |
| 74 | PTK2B | 0.76669229 |
| 75 | TBK1 | 0.75886224 |
| 76 | KDR | 0.71010683 |
| 77 | FGFR2 | 0.70557341 |
| 78 | CAMK1D | 0.70232986 |
| 79 | RET | 0.69812307 |
| 80 | PRKCH | 0.69733890 |
| 81 | WEE1 | 0.69283517 |
| 82 | CAMKK2 | 0.69192128 |
| 83 | DYRK1B | 0.68323635 |
| 84 | ERBB4 | 0.67051876 |
| 85 | MAP2K3 | 0.66532349 |
| 86 | IRAK1 | 0.66435125 |
| 87 | TSSK6 | 0.65204862 |
| 88 | PDGFRB | 0.64955604 |
| 89 | PRKCI | 0.64242391 |
| 90 | CSK | 0.63573695 |
| 91 | STK10 | 0.61403884 |
| 92 | PNCK | 0.61054697 |
| 93 | NLK | 0.60269823 |
| 94 | EIF2AK2 | 0.58505412 |
| 95 | IKBKB | 0.57989024 |
| 96 | MST4 | 0.57802621 |
| 97 | MTOR | 0.57733075 |
| 98 | MAPK11 | 0.57545550 |
| 99 | NTRK1 | 0.57207491 |
| 100 | NEK1 | 0.56099454 |
| 101 | GSK3A | 0.55230808 |
| 102 | CSNK1G3 | 0.54446897 |
| 103 | PBK | 0.52026088 |
| 104 | PRKD3 | 0.51757885 |
| 105 | STK3 | 0.51378860 |
| 106 | IGF1R | 0.51195469 |
| 107 | MARK3 | 0.51064194 |
| 108 | LIMK1 | 0.49894348 |
| 109 | TEC | 0.49607361 |
| 110 | MAP3K10 | 0.49447058 |
| 111 | MAPKAPK3 | 0.49237842 |
| 112 | CSNK1G2 | 0.48312400 |
| 113 | BTK | 0.47789908 |
| 114 | MAP3K7 | 0.47138696 |
| 115 | PAK2 | 0.46852421 |
| 116 | PRKAA1 | 0.46752790 |
| 117 | PRKAA2 | 0.45728454 |
| 118 | IKBKE | 0.45390329 |
| 119 | MAP2K6 | 0.45019005 |
| 120 | TTN | 0.44194614 |
| 121 | MAPKAPK5 | 0.44108507 |
| 122 | LMTK2 | 0.43311976 |
| 123 | TESK1 | 0.42893370 |
| 124 | CAMK1G | 0.42789531 |
| 125 | PIK3CA | 0.42751500 |
| 126 | ROCK1 | 0.42302655 |
| 127 | PLK4 | 0.42160938 |
| 128 | EEF2K | 0.41868622 |
| 129 | PRKD1 | 0.41674435 |
| 130 | ABL1 | 0.41051920 |
| 131 | PAK3 | 0.40103739 |
| 132 | CAMK2D | 0.39920581 |
| 133 | PDPK1 | 0.38436675 |
| 134 | STK16 | 0.37937108 |
| 135 | CDK6 | 0.37556396 |
| 136 | TAF1 | 0.36242718 |
| 137 | ADRBK1 | 0.35572062 |
| 138 | STK39 | 0.35424712 |
| 139 | MAP3K14 | 0.34548048 |
| 140 | EPHA2 | 0.34290264 |
| 141 | TIE1 | 0.33997411 |
| 142 | TXK | 0.33957585 |
| 143 | GRK7 | 0.33766777 |
| 144 | BRSK2 | 0.33292915 |
| 145 | EGFR | 0.32827679 |
| 146 | DAPK2 | 0.32709768 |
| 147 | PRKCQ | 0.31688955 |
| 148 | PINK1 | 0.31488531 |
| 149 | TGFBR1 | 0.31036645 |
| 150 | FGFR1 | 0.29687588 |
| 151 | BUB1 | 0.29620187 |
| 152 | PDK1 | 0.27651565 |
| 153 | ERBB2 | 0.27563768 |
| 154 | CSNK1A1L | 0.27558545 |
| 155 | ABL2 | 0.27466803 |
| 156 | STK4 | 0.27220370 |
| 157 | YES1 | 0.26883474 |
| 158 | MAP2K1 | 0.26818785 |
| 159 | ATM | 0.26558122 |
| 160 | PLK1 | 0.26269540 |
| 161 | PRKD2 | 0.25959584 |
| 162 | MAP4K1 | 0.25709625 |
| 163 | PRKACG | 0.25660612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.29064240 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33901938 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05141583 |
| 4 | Protein export_Homo sapiens_hsa03060 | 2.93019331 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.90403755 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.79333794 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.59806894 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50166543 |
| 9 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.45684767 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42721245 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.29715034 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.19344671 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.16647412 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.13018231 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95697825 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91773023 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.91008097 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.90396265 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.81287118 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74404060 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.72770355 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.70227265 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69056281 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.68707326 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.68524700 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.55131633 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.54719912 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50899594 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.50593438 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49543907 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.46628812 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.45517097 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44226450 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39844489 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37707945 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35097810 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.32611226 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31139608 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28927452 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.28513064 |
| 41 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25990315 |
| 42 | Mineral absorption_Homo sapiens_hsa04978 | 1.24757438 |
| 43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.23592070 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22544873 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.21851105 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21565688 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19031506 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.14264917 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13450578 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12382352 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11311992 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.08371473 |
| 53 | Homologous recombination_Homo sapiens_hsa03440 | 1.07579032 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07185804 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.07142681 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05461247 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04956684 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.04499775 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98539737 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.96469540 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95843351 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95164911 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90658102 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89662631 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89375136 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.88612484 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88037123 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87401469 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.87305334 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85756659 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.84126638 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82490880 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81384228 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80566817 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79324403 |
| 76 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.76813676 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72535011 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69753287 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69629280 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69349248 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.68504338 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68449230 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67553231 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65477094 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.64327816 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64250336 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.63930536 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63302750 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61502441 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60930490 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.60261792 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59453565 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.56743452 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56508532 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54317755 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53214637 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51890972 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49539597 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45884448 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44957578 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44500474 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44466996 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44107804 |
| 104 | RNA polymerase_Homo sapiens_hsa03020 | 0.44000139 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43538788 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42763503 |
| 107 | Insulin secretion_Homo sapiens_hsa04911 | 0.41377894 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41281975 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.39987071 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39755555 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38654316 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36320595 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35991573 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.35367338 |
| 115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34731352 |
| 116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.34726298 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31197168 |
| 118 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30548635 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30086681 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.28734669 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28602348 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27967599 |
| 123 | Mismatch repair_Homo sapiens_hsa03430 | 0.27230150 |
| 124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.27218803 |
| 125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.26893709 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26796178 |
| 127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.26741557 |
| 128 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26681750 |
| 129 | Asthma_Homo sapiens_hsa05310 | 0.26668699 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24323561 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23447350 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22193217 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.19178045 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | 0.17261082 |
| 135 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.14667100 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13765026 |
| 137 | Legionellosis_Homo sapiens_hsa05134 | 0.13189078 |

